A CLARION CALL TO ALL INDIANS TO FACILITATE INTENSE RESEARCH ON NATURAL PRODUCTS
Journal: Indian Drugs (Vol.57, No. 01)Publication Date: 2020-01-28
Authors : Gopakumar G. Nair;
Page : 5-6
Keywords : Editor; Indian Drugs;
Abstract
Dr. Gopakumar G. Nair is a Ph.D in Organic Chemistry (1966) from National Chemical Laboratory Pune (Pune University). He was a Post-Doctoral fellow at IIT Bombay, Powai (1967) before joining the Pharma Industry. He was Director of Bombay Drug House P. Ltd., later Chairman of BDH Industries Ltd. as well as CMD of Bombay Drugs & Pharma Ltd., which was merged with Strides Arcolab Ltd. in 2001. Dr. Nair served IDMA as office bearer for many years from 1972 onwards and was Chairman of various Committees for nearly 4 decades. He was the President of IDMA in 1999/2000. Currently, Dr. Nair is the Chairman of the IPR Committee in IDMA.
Having moved into the Intellectual Property field, he was the Dean of IIPS (Institute of Intellectual Property Studies) at Hyderabad in 2001/2002. Later, he set up his own boutique IP firm, Gopakumar Nair Associates, as well as Gnanlex Hermeneutics Pvt. Ltd., having done his L. L. B. from Mumbai University. He is also CEO of Patent Gurukul and President of Bharat Education Society, Kurla, Mumbai, managing many educational institutions in and around Mumbai.
Other Latest Articles
- Isolation, Phytochemical Screening and Pharmacological Evaluation of Tagetes erecta Leaves Extract
- To Study the Correlation Between 24 Hour Urinary Protein and Spot Urinary Albumin to Creatinine Ratio and
- Prevalence of Obesity in Correlation with Physical Activity among School Students of Nepal
- Efficacy and Safety of Subcutaneous Fat Reduction by Cryoadipolysis
- Leading the Charge by Dr. Rahul Ravilla: The Newer Immune-Related Side-Effects Impacts Continuity of Care in Individuals with Cancer on Immune Checkpoint Inhibitors
Last modified: 2020-02-27 13:09:57